44 /100
MEDIUM RISK
Score updated Jun 16, 2026

COAG — Hemab Therapeutics Holdings, Inc. Dilution Risk Tracker

Track COAG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COAG — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
100
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for COAG.
🔔 Track COAG — Get forecast alerts →

💹 Market Data

Market Cap$1.33B
Shares Outstanding46.71M
FloatN/A
Cash$163.53M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

59.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track COAG for full holder detail →

📉 Short Interest

Short Interest758.7K
Days to Cover1.2
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track COAG Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking COAG — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT ACH ADUR AFJK AHRT

Browse all 7,800+ tracked stocks →

🔬 More Research for COAG
📊 COAG FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 COAG Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.